Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Adrenergic Receptor
    (23)
  • PDE
    (20)
  • Leukotriene Receptor
    (17)
  • Histamine Receptor
    (14)
  • IL Receptor
    (11)
  • Endogenous Metabolite
    (10)
  • AChR
    (9)
  • Glucocorticoid Receptor
    (8)
  • Lipoxygenase
    (7)
  • Others
    (145)
Filter
Search Result
Results for "

asthma

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    357
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    2
    TargetMol | Compound_Libraries
  • Peptide Products
    8
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    16
    TargetMol | Inhibitory_Antibodies
  • PROTAC Products
    1
    TargetMol | PROTAC
  • Natural Products
    27
    TargetMol | Natural_Products
  • Recombinant Protein
    29
    TargetMol | Recombinant_Protein
  • Isotope Products
    11
    TargetMol | Isotope_Products
  • Antibody Products
    1
    TargetMol | Antibody_Products
  • Cell Research
    4
    TargetMol | Inhibitors_Agonists
Ipratropium bromide monohydrate
Ipratropium bromide hydrate
T009866985-17-9
Ipratropium bromide monohydrate (Ipratropium bromide hydrate) is a muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic.
  • Inquiry Price
Size
QTY
Doxofylline
Doxophylline
T048069975-86-6
Doxofylline (Doxophylline) is a methylxanthine derivative with the presence of a dioxolane group in position 7. As a drug used in the treatment of asthma, doxofylline has shown similar efficacy to theophylline but with significantly fewer side effects in animal and human studies.
  • Inquiry Price
Size
QTY
Theophylline monohydrate
Quibron
T1083L5967-84-0
Theophylline monohydrate (Quibron) appears to inhibit phosphodiesterase and prostaglandin production, regulate calcium flux and intracellular calcium distribution, and antagonize adenosine. Theophylline monohydrate is a natural alkaloid derivative of xanthine isolated from the plants Camellia sinensis and Coffea arabica. Physiologically, this agent relaxes the bronchial smooth muscle, produces vasodilation (except in cerebral vessels), stimulates the CNS, stimulates the cardiac muscle, induces diuresis, and increases gastric acid secretion; it may also suppress inflammation and improve contractility of the diaphragm.
  • Inquiry Price
Size
QTY
Montelukast sodium
MK0476
T1677L151767-02-1
Montelukast sodium (MK0476) is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma and has been linked to rare cases of clinically apparent liver injury.
  • Inquiry Price
Size
QTY
Ibudilast
MN-166, KC-404, AV-411
T213750847-11-5
Ibudilast (MN-166)(KC-404;AV-411;MN-166) is a relatively nonselective phosphodiesterase inhibitor. It is approved for use as an anti-inflammatory in Japan.
  • Inquiry Price
Size
QTY
Setipiprant
KYTH-105, ACT-129968
T3520866460-33-5
Setipiprant (ACT-129968) is an orally available, selective CRTH2 antagonist (IC50: 6.0 nM). CRTH2, a G protein-coupled receptor for prostaglandin (PGD2), mediates key inflammatory responses related to allergy and asthma. PGD2, produced by mast cells, binds to CRTH2 on blood-borne cells, inducing chemotaxis of Th2 cells, basophils, and eosinophils, and stimulating cytokine release.
  • Inquiry Price
Size
QTY
Cilomilast
SB-207499, Ariflo
T6445153259-65-5
Cilomilast (SB-207499) is a potent PDE4 inhibitor with an IC50 of approximately 110 nM, demonstrating anti-inflammatory activity and minimal central nervous system effects. Phase 3.
  • Inquiry Price
Size
QTY
Omalizumab
T9926242138-07-4
Omalizumab is a recombinant humanized monoclonal antibody against human immunoglobulin E IgE)
  • Inquiry Price
Size
QTY
Sulfuretin
TN2244120-05-8
Sulfuretin is a potent anti-oxidant, has protective effect against t-BHP-induced oxidative damage in human liver-derived HepG2 cells is attributable to its ability to scavenge ROS and up-regulate the activity of HO-1 through the Nrf2 ARE and JNK ERK signa
  • Inquiry Price
Size
QTY
Asthma relating compound 1
T10508120165-51-7
Asthma relating compound 1 is a potential anti-asthma compound.
  • Inquiry Price
6-8 weeks
Size
QTY
Antiasthmatic Compound 1
T1016163768-49-0In house
Antiasthmatic Compound 1 is an antiasthmatic agent.
  • Inquiry Price
6-8 weeks
Size
QTY
Tezepelumab
Tezepelumab-ekko, MEDI 19929, AMG 157
T773591572943-04-4
Tezepelumab (AMG 157) is a humanized monoclonal antibody (IgG2λ) targeting TSLP that prevents TSLP from interacting with its heterodimer receptor. Tezepelumab can be used to study advanced asthma disease.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Rocaglamide
Rocaglamide A, Roc-A
TQ013184573-16-0
Rocaglamide (Roc-A), isolated from the genus Aglaia, can be used to treat coughs, injuries, asthma, and inflammatory skin diseases. It is a potent inhibitor of NF-κB activation in T-cells.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
3-CPs
3-Carbethoxypsoralen, 3-Ethoxycarbonylpsoralen
T1011020073-24-9In house
3-CPs (3-Carbethoxypsoralen) is a bleomycin-induced serotypic podoplanar polysaccharide in mouse lung fibrosis that belongs to the psoralen family and interferes with antibody-mediated bacterial killing.3-CPs delays bleomycin-induced lung fibrosis in mice and can be used in studies of airway inflammation and asthma.
  • Inquiry Price
Size
QTY
PDE IV-IN-1
T10201225100-12-9In house
PDE IV-IN-1 is a potent phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory activity for the treatment of asthma, chronic obstructive pulmonary disease and other inflammatory diseases, and is a potential compound for the study of depression.
  • Inquiry Price
6-8 weeks
Size
QTY
TargetMol | Inhibitor Sale
A-69412
N-1-(Fur-3-ylethyl)-N-hydroxyurea
T10208123606-23-5In house
A-69412 (N-1-(Fur-3-ylethyl)-N-hydroxyurea) is a reversible, specific inhibitor of the hydrophilic 5-lipoxygenase. It has the potential to treat ulcerative colitis and asthma, and possibly other inflammatory and allergic conditions.
  • Inquiry Price
6-8 weeks
Size
QTY
CP 96021
T10872L139401-43-7In house
CP 96021 is a group of 5-HT1 receptors and 5-HT2 receptors antagonists that have anti-inflammatory properties and are non-non-self anti-ulcer compounds for the treatment of gastrointestinal tract and respiratory asthma.
  • Inquiry Price
6-8weeks
Size
QTY
TargetMol | Inhibitor Sale
Gemilukast
ONO-6950
T113881232861-58-3In house
Gemilukast (ONO-6950) is an orally active and potent dual inhibitor of cysteinyl leukotriene 1 and 2 receptors (CysLT1 and CysLT2), inhibits LTC 4-induced bronchoconstriction, and is inhibitory to human CysLT1 and CysLT2, and may be used in the treatment of asthma.
  • Inquiry Price
10-14 weeks
Size
QTY
HSR6071
T11581111374-21-1In house
HSR6071 is a novel orally active and potent anti-allergic agent with inhibitory effects on passive cutaneous anaphylaxis. HSR6071 showed anti-asthmatic activity in a rat model of experimental asthma.
  • Inquiry Price
6-8 weeks
Size
QTY
RS-601
T12771207987-59-5In house
RS-601 is a potent dual leukotriene D4 thromboxane A2 inhibitor that inhibits antigen-induced airway hyperresponsiveness (AHR) and shows asthmatic effects in a guinea pig model of asthma.
  • Inquiry Price
6-8 weeks
Size
QTY
ZK-90055 hydrochloride
ZK 90055 hydrochloride, ZK90055 hydrochloride
T1340384638-81-3In house
ZK-90055 hydrochloride, a β2 adrenergic receptor agonist, is employed in the study of asthma.
  • Inquiry Price
6-8 weeks
Size
QTY
Tipelukast
MN 001, KCA 757
T15647125961-82-2In house
Tipelukast (KCA 757) is a novel, orally available leukotriene receptor antagonist with anti-inflammatory properties, capable of reducing fibrosis and down-regulating TIMP-1 and type 1 collagen. Tipelukast is utilized in asthma research.
  • Inquiry Price
10-14 weeks
Size
QTY
KP136
AL136
T1566676239-32-2In house
KP136 (AL136) is an orally active anti-allergic compound that inhibits histamine release and is used in studies of asthma and allergic edema.
  • Inquiry Price
6-8 weeks
Size
QTY
LAS101057
T15715925676-48-8In house
LAS101057 is a novel orally available and potent and selective A2B receptor antagonist for the study of asthma.
  • Inquiry Price
7-10 days
Size
QTY